Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.

× No keyword cloud information.

15 in total

1. Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.

Authors: Shancheng Ren; Chuanliang Xu; Zilian Cui; Yongwei Yu; Weidong Xu; Fubo Wang; Ji Lu; Min Wei; Xin Lu; Xu Gao; You Liang; Jian-Hua Mao; Yinghao Sun
Journal: J Mol Med (Berl) Date: 2012-03-16 Impact factor: 4.599

2. Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment.

Authors: Gabriela R Passos; Juliana A Camargo; Karen L Ferrari; Mário J A Saad; Amilcar C de Mattos; Leonardo O Reis
Journal: Med Oncol Date: 2017-12-04 Impact factor: 3.064

3. Deptor knockdown enhances mTOR Activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy.

Authors: Abid A Kazi; Ly Hong-Brown; Susan M Lang; Charles H Lang
Journal: Mol Med Date: 2011-05-19 Impact factor: 6.354

Review 4. Small molecule therapeutics targeting F-box proteins in cancer.

Authors: Yuan Liu; Rama K Mallampalli
Journal: Semin Cancer Biol Date: 2015-09-30 Impact factor: 15.707

Review 5. DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Authors: Zhiwei Wang; Jiateng Zhong; Daming Gao; Hiroyuki Inuzuka; Pengda Liu; Wenyi Wei
Journal: Am J Physiol Endocrinol Metab Date: 2012-03-27 Impact factor: 4.310

Review 6. The genetic architecture of multiple myeloma.

Authors: Gareth J Morgan; Brian A Walker; Faith E Davies
Journal: Nat Rev Cancer Date: 2012-04-12 Impact factor: 60.716

Review 7. An evolving role for DEPTOR in tumor development and progression.

Authors: Zhiwei Wang; Jiateng Zhong; Hiroyuki Inuzuka; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal: Neoplasia Date: 2012-05 Impact factor: 5.715

8. Understanding the multiple biological aspects leading to myeloma.

Authors: Eileen M Boyle; Faith E Davies; Xavier Leleu; Gareth J Morgan
Journal: Haematologica Date: 2014-04 Impact factor: 9.941

9. DEPTOR is linked to a TORC1-p21 survival proliferation pathway in multiple myeloma cells.

Authors: Yonghui Yang; Carolyne Bardeleben; Patrick Frost; Bao Hoang; Yijiang Shi; Richard Finn; Joseph Gera; Alan Lichtenstein
Journal: Genes Cancer Date: 2014-11

Review 10. The genetic architecture of multiple myeloma.

Authors: Steven M Prideaux; Emma Conway O'Brien; Timothy J Chevassut
Journal: Adv Hematol Date: 2014-04-03